Chinese medicinal formula for treating chronic virus B hepatitis

A technology for viral hepatitis and type B, applied in pharmaceutical formulations, antiviral agents, medical preparations containing active ingredients, etc., can solve problems such as patient discomfort

Inactive Publication Date: 2012-02-08
陈登
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The hepatitis B vaccine in the traditional sense can effectively prevent and treat a large number of hepatitis viruses, but due to individual differences, many patients still have discomfort

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0005] Put flat wood, knotweed, barbata, weeping grass, turmeric, smilax, red peony, black beans and raw licorice, etc., in a sand pot, add a little cold water to soak the medicinal noodles, and soak for 20 minutes Cook again. After boiling, use low heat to fry for about 15 minutes, filter the medicinal liquid and take it warmly.

[0006] One dose per day, decocted twice, once in the morning and once in the afternoon, and taken two hours after meals. Take two months as a course of treatment. Generally, 2-3 courses of treatment should be taken. Before treatment and every full course of treatment, liver function and hepatitis B virus infection surface antibody antigen markers can be rechecked once.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a Chinese medicinal formula for treating chronic virus B hepatitis, which is a worldwide disease caused by hepatitis B virus. According to statistics, the number of asymptomatic HBV (hepatitis B virus) carrier exceeds 280 million all over the world, and China accounts for 45%. Most of the patients are asymptomatic, and 1/3 of the patients show liver damage clinically. Currently, the number of hepatitis B patients in China totals 30 million. Hepatitis B is characterized by slow onset, and common subclinical and chronic types. And patients with persistent positive non-icteric HBsAg (hepatitis B surface antigen) are likely to become chronic. The disease of chronic virus B hepatitis is mainly transmitted by means of blood, mother-baby, and sexual contact. Virus B hepatitis vaccines in the traditional sense can prevent and treat a lot of hepatitis viruses effectively, but due to individual differences, many patients still show maladjustment.

Description

【Technical field】 [0001] The invention relates to a traditional Chinese medicine formula for treating hepatitis, in particular to a traditional Chinese medicine formula for treating chronic hepatitis B. 【Background technique】 [0002] Hepatitis B is a worldwide disease caused by the hepatitis B virus. According to statistics, there are more than 280 million asymptomatic hepatitis B virus carriers in the world, and my country accounts for about 45%. Most of them are asymptomatic, and 1 / 3 of them have clinical manifestations of liver damage. At present, there are 30 million hepatitis B patients in our country. Hepatitis B is characterized by slow onset, and subclinical and chronic types are more common. Anicteric HBsAg persistently positive patients tend to become chronic. The disease is mainly transmitted through blood, mother-to-child and sexual contact. The hepatitis B vaccine in the traditional sense can effectively prevent and treat a large number of hepatitis viruse...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P1/16A61P31/20
Inventor 陈登
Owner 陈登
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products